IL-37: A new anti-inflammatory cytokine of the IL-1 family

European Cytokine Network

Volumn 22, Issue 3, 2011, Pages 127-147

  Boraschi, Diana ^a   Lucchesi, Davide ^a   Hainzl, Stefan ^b   Leitner, Maria ^b   Maier, Elisabeth ^b   Mangelberger, Doris ^b   Oostingh, Gertie J ^b   Pfaller, Tobias ^b   Pixner, Claudia ^b   Posselt, Gernot ^b   Italiani, Paola ^a   Nold, Marcel F ^c,d   Nold Petry, Claudia A ^c,d   Bufler, Philip ^e   Dinarello, Charles A ^c  

^a CNR   (Italy)

^b UNIVERSITY OF SALZBURG   (Austria)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

IL 1 cytokines; IL 18; IL 18BP; IL 1F7; IL 37; Inflammation

Indexed keywords

CELL PROTEIN; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR ANTAGONIST; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROTEIN INTERLEUKIN 37; UNCLASSIFIED DRUG;

ALPHA CHAIN; GENE EXPRESSION; INFLAMMATION; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL;

ANIMALS; DISEASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION;

EID: 83055163376     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2011.0288     Document Type: Review

References (95)

1. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998; 16: 457.
2. Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator ofToll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4: 920.
3. Garlanda C, Riva F, Polentarutti N, et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004; 101: 3522.
4. Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 2004; 4: 378.
5. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479.
6. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007; 104: 18660.
7. Costelloe C, Watson M, Murphy A, et al. IL-1F5 mediates antiinflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J Neurochem 2008; 105: 1960.
8. Dinarello CA, Arend W, Sims J, et al. IL-1 family nomenclature. Nat Immunol 2010; 11: 973.
9. Boraschi D, Tagliabue A. The interleukin-1 receptor family. In: Litwak G, Ed. Interleukins, Vitamins and Hormones, San Diego/Amsterdam: Academic Press/Elsevier, 2006; 74: 229.
10. Mitcham JL, Parnet P, Bonnert TP, et al. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem 1996; 271: 5777.
11. Thomassen E, Renshaw BR, Sims JE. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 1999; 11: 389.
12. Khan JA, Brint EK, O'Neill LA, Tong L. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J BiolChem 2004; 279: 31664.
13. Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem 2000; 275: 29946.
14. Ferrante MI, Ghiani M, Bulfone A, Franco B. IL1RAPL2 maps to Xq22 and is specifically expressed in the central nervous system. Gene 2001; 275: 217.
15. Sana TR, Debets R, Timans JC, Bazan JF, Kastelein RA. Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. Genomics 2000; 69: 252.
16. Behnecke A, Hinderhofer K, Bartsch O, et al. Intragenic deletions of IL1RAPL1: Report of two cases and review of the literature. Am J Med Genet A 2011; 155A: 372.
17. Pavlowsky A, Zanchi A, Pallotto M, et al. Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions. Commun Integr Biol 2010; 3: 245.
18. Bahi N, Friocourt G, Carrié A, et al. IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 2003; 12: 1415.
19. Gambino F, Pavlowsky A, Béglé A, et al. IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type C2+a-channel and neurite elongation. Proc Natl Acad Sci USA 2007; 104: 9063.
20. Carrié A, Jun L, Bienvenu T, et al. Anewmember of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999; 23: 25.
21. Lang D, Knop J, Wesche H, et al. The type II interleukin-1 receptor interacts with the interleukin-1 receptor accessory protein: a novel mechanism of regulation of the interleukin-1 responsiveness. J Immunol 1998; 161: 6871.
22. Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol 2004; 75: 738.
23. Garlanda C, Anders HJ, Mantovani A. TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization. Trends Immunol 2009; 30: 439.
24. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12: 59.
25. Bossù P, Neumann D, Del Giudice E, et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci USA 2003; 100: 14181.
26. Boraschi D, Dinarello CA. IL-18 and autoimmunity. Eur Cytokine Netw 2006; 17: 224.
27. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2007; 156: 479.
28. Torigoe K, Ushio S, Okura T, et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997; 272: 25737.
29. Meng X, Leman M, Xiang Y. Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 2007; 358: 211.
30. Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleukin-1F7b (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7b binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 2002; 18: 61.
31. Reznikov LL, Kim SH, Zhou L, Bufler P, Goncharov I, Tsang M, Dinarello CA. The combination of soluble IL-18Ra and IL-18Rß chains inhibits IL-18-induced IFN-?. J Interferon Cytokine Res 2002; 22: 593.
32. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999; 10: 127.
33. Kim S-H, Eisenstein M, Reznivok LL, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000; 97: 1190.
34. Nold M, Hauser IA, Hoefler S, et al. IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole blood. Biochem Pharmcol 2003; 66: 505.
35. Tak PP, Bacchi M, Bertolino M. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharmacokinetics 2006; 31: 109.
36. Banda NK, Vondracek A, Kraus D, et al. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol 2003; 170: 2100.
37. Lewis EC, Dinarello CA. Responses of IL-18 and IL-18 receptordeficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci USA 2006; 103: 16852.
38. Gutcher I, Urich E, Wolter K, Prinz M, Becher B. Interleukin 18- independent engagement of interleukin 18 receptor-a is required for autoimmune inflammation. Nat Immunol 2006; 7: 946.
39. Nold-Petry CA, Nold MF, Nielsen JW, et al. Increased cytokine production in interleukin-18 receptor a-deficient cells is associated with dysregulation of suppressors of cytokine signalling. J Biol Chem 2009; 284: 25900.
40. Pan G, Risser P, Mao W, et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001; 13: 1.
41. Bufler P, Azam T, Gamboni-Robertson F, et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002; 99: 13723.
42. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, Sims JE. Four new members expand the interleukin-1 superfamily. Proc Natl Acad Sci USA 2000; 275: 1169.
43. Kumar S, McDonnell PC, Lehr R, et al. Identification and initial characterization of four novel members of the interleukin-1 family. Proc Natl Acad Sci USA 2000; 275: 10308.
44. Busfield SJ, Cormack CA, Yu G, et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000; 66: 213.
45. Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics 2002; 79: 726.
46. Mulero JJ, Pace AM, Nelken ST, et al. IL1HY1: A novel interleukin-1 receptor antagonist gene. Biochem Biophys Res Commun 1999; 263: 702.
47. Lin H, Ho AS, Haley-Vicente D, et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 2001; 276: 20597.
48. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998; 51: 161.
49. Nicklin MJH, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002; 79: 718.
50. Newman TL, Tuzun E, Morrsion VA, et al. Genome-wide survey of structural variation between human and chimpanzee. Genome Res 2005; 15: 1344.
51. Zimin AV, Delcher AL, Florea L, et al. A whole-genome assembly of the domestic cow. Bos taurus. Genome Biol 2009; 10: R42.
52. Bufler P, Gamboni-Robertson F, Azam T, Kim S-H, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381: 503.
53. Murzin AG, Lesk AM, Chothia C. ß-trefoil fold Patterns of structure and sequence in the Kunitz inhibitors interleukins-1ß and 1a and fibroblast growth factors. J Mol Biol 1992; 223: 531.
54. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11: 1014.
55. Keller M, Rügg A, Werner S, Beer HD. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008; 132: 818.
56. Sharma S, Kulk N, Nold MF, et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008; 180: 5477.
57. Lingel A, Weiss TM, Niebuhr M, et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 2009; 17: 1398.
58. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-_B and MAPKs. J Biol Chem 2004; 279: 13677.
59. Azam T, Novick D, Bufler P, et al. Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 binding complex. J Immunol 2003; 171: 6574.
60. Kim SH, Azam T, Yoon DY, et al. Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein. Proc Natl Acad Sci USA 2001; 98: 3304.
61. Kato Z, Jee J, Shikano H, et al. The structure and binding mode of interleukin-18. Nat Struct Biol 2003; 10: 966.
62. Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Computat Chem 1998; 19: 1639.
63. Debets R, Timans JC, Homey B, et al. Two novel IL-1 family members IL-1_ and IL-1_, function as an antagonist and agonist of NF-_B activation through the orphan IL-1 receptor-related protein 2. J Immunol 2001; 167: 1440.
64. Garlanda C, Riva F, Veliz T, et al. Increased susceptibility to colitisassociated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 2007; 67: 6017.
65. Xiao H, Gulen MF, Qin J, et al. The Toll-Interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007; 26: 461.
66. Magne D, Palmer G, Barton JL, et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther 2006; 8: R80.
67. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095.
68. Werman A, Werman-Venkert R, White R, et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 2004; 101: 2434.
69. Wessendorf JH, Garfinkel S, Zhan X, Brown S, Maciag T. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J Biol Chem 1993; 268: 22100.
70. McMahon GA, Garfinkel S, Prudovsky I, Hu X, Maciag T. Intracellular precursor interleukin (IL)-1α, but not mature IL-1α, is able to regulate human endothelial cell migration in vitro. J Biol Chem 1997; 272: 28202.
71. Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM. A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc Natl Acad Sci USA 2003; 100: 10008.
72. Buryskova M, Pospisek M, Grothey A, Simmet T, Burysek L. Intracellular interleukin-1_ functionally interacts with histone acetyltransferase complexes. J Biol Chem 2004; 279: 4017.
73. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248.
74. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191.
75. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007; 220: 35.
76. Baekkevold ES, Roussigné M, Yamanaka T, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressedin human high endothelial venules. Am J Pathol 2003; 163: 69.
77. Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104: 282.
78. Ali S, Nguyen DQ, Falk W, Martin MU.Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem Biophys Res Commun 2010; 391: 1512.
79. Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22: 5551.
80. Kaplanski G, Farnarier C, Kaplanski S, et al. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84: 4242.
81. Kurt-Jones EA, Fiers W, Pober JS. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol 1987; 139: 2317.
82. De Castro E, Sigrist CJ, Gattiker A, et al. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 2006; 34 (Web Server issue): W362.
83. Grimsby S, Jaensson H, Dubrovska A, Lomnytska M, Hellman U, Souchelnytskyi S. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity. FEBS Lett 2004; 577: 93.
84. McNamee EN, Masterson JC, Jedlicka P, et al. Interleukin-37 protects mice from colitis. Proc Natl Acad Sci USA 2011 (in press).
85. Gao W, Kumar S, Lotz e MT, Hanning C, Robbins PD, Gambotto A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J Immunol 2003; 170: 107.
86. Lin L, Peng SL. Interleukin-18 receptor signalling is not required for autoantibody production and end-organ disease in murime lupus. Arthr Rheum 2005; 52: 984.
87. Esfandiari E, McInnes IB, Lindop G, et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167: 5338.
88. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007; 27: 98.
89. Ishikawa Y, Yoshimoto T, Nakanishi K. Contribution of IL-18- induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. Int Immunol 2006; 18: 847.
90. Yoshimoto T, Tsutsui H, Tominaga K, et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999; 96: 13962.
91. Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, Tilg H. Adipose and liver expression of IL-1 family members in morbid obesity and effects of weight loss. Mol Med 2011 [Epub ahead of print].
92. Muhr P, Zeitvogel J, Heitland I, Werfel T, Wittmann M. Expression of IL-1 family members upon stimulation with IL-17 differs in keratinocytes derived from psoriasis patients and healthy donors. Br J Dermatol 2011; 165: 189.
93. Rahman P, Sun S, Peddle L, et al. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006; 54: 2321.
94. Pan F, Liao F, Xia G, et al. Association of IL1F7 gene with suceptibility to human leukocyte antigen-B27 positive ankylosing spondilitis in Han Chinese population. Clin Chim Acta 2010; 411: 124.
95. Ge R, Pan F, Liao F, et al. Analysis of the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondilitis: a case-only study. Mol Biol Rep 2011; 38: 2281. in human high endothelial venules. Am J Pathol 2003; 163: 69.